Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
MarketingRx Matchup: How AbbVie and Biohaven ads rank in head-to-head migraine challenge
4 years ago
Pharma
Marketing
Q&A: Organon chief communications officer Wendy Lund talks about the Merck spinoff, women’s health and why it ...
4 years ago
Pharma
Marketing
MarketingRx roundup: Pfizer re-ups pneumonia ads as Merck threat looms; Real Chemistry founder CEO Jim Weiss steps ...
4 years ago
Pharma
Marketing
Merck pumps the brakes on two more PhIII trials for its lead anti-HIV drug
4 years ago
R&D
vTv Therapeutics cuts 65% of employees in shakeup; Freenome bags $300M in Series D to expand multiomics platform
4 years ago
News Briefing
London AI-focused BenevolentAI going public in Europe via $438M SPAC deal
4 years ago
Financing
AI
Acadia touts late-stage win for its Rett syndrome drug, edging out a lead against its competitors
4 years ago
R&D
Covid-19 roundup: Plant-based shot proves safe, 71% efficacious in PhIII; Bourla expects antiviral to launch this ...
4 years ago
Coronavirus
Can a new European biotech make an ADC better than Padcev? Investors are putting up almost $100M to find out
4 years ago
Financing
Richard Lerner, antibody pioneer and longtime president of Scripps Research, dies at 83
4 years ago
People
'We're in': Roche and Genentech join forces on a multibillion-dollar discovery pact with a brash AI upstart
4 years ago
Deals
Bioregnum
Icelandic billionare's biosimilar company raises $450M, preps for Nasdaq launch with SPAC merger
4 years ago
Financing
Startups
AstraZeneca grabs PhIII ATTR drug from Ionis — infusing $200M cash into struggling partner
4 years ago
Deals
Always busy, Gary Glick recruits OrbiMed in a massive $218M Series A for enigmatic data science biotech
4 years ago
People
Financing
Special report: Meet 20 extraordinary women who are supercharging biopharma R&D
4 years ago
People
Special
Transpacific AI biotech makes its Series A debut — putting $86M in the bank
4 years ago
Financing
Startups
Apple Tree Partners leaps across the pond to launch a UK biotech looking to crack the secrets of dendritic cells
4 years ago
Financing
Startups
WHO recommends against the use of convalescent plasma for Covid-19
4 years ago
Coronavirus
Digital clutter threatens pharma-to-physician relationships in shift to next era of communications
4 years ago
Pharma
Marketing
Klick Health hands out $100 bills in annual holiday greeting that’s turned into default recruiting tool
4 years ago
Pharma
Marketing
Seattle biotech closes $18M Series B — and acquires a company; Another George Church alum launches upstart
4 years ago
News Briefing
FDA slams Reata's kidney drug as ineffective ahead of adcomm meeting
4 years ago
Pharma
FDA+
Recordati acquires EUSA Pharma and its 4 rare disease drugs, but analysts question strategy behind the deal
4 years ago
Deals
Bolt Bio goes bust as investors boo single response in early test against HER2-expressing tumors
4 years ago
R&D
First page
Previous page
613
614
615
616
617
618
619
Next page
Last page